Denosumab promising in GCT
12 February 2010
| by Nicola Garrett
The monoclonal antibody denosumab may be a promising treatment in some patients with inoperable giant-cell tumour (GCT) of bone, research shows....
Want to read complete article? Please Sign in or Register.